PodParley PodParley
PodParley
20. Hair dye and breast cancer commentary - Basosquamous cell carcinomas are BCCs with ARID1a mutations - Dupilumab for kids under 12 - Rifampicin-moxifloxacin-metronidazole (RMoM) works for HS - Nado episode artwork

EPISODE · Feb 10, 2020 · 1H 24M

20. Hair dye and breast cancer commentary - Basosquamous cell carcinomas are BCCs with ARID1a mutations - Dupilumab for kids under 12 - Rifampicin-moxifloxacin-metronidazole (RMoM) works for HS - Nado

from Dermasphere - The Dermatology Podcast · host Luke Johnson

Hair dye and breast cancer commentary [article]Basosquamous cell carcinomas are BCCs with ARID1a mutations [article]Dupilumab for kids under 12 [article]Rifampicin-moxifloxacin-metronidazole (RMoM) works for HS [article]Nadolol-induced death in infantile hemangioma [article]Dermasphere clip show - episodes 11-20! [archives]

Episode metadata supplied by the publisher feed · Published Feb 10, 2020

Embed this episode

Ready to play

20. Hair dye and breast cancer commentary - Basosquamous cell carcinomas are BCCs with ARID1a mutations - Dupilumab for kids under 12 - Rifampicin-moxifloxacin-metronidazole (RMoM) works for HS - Nado

0:00 1:24:40

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dermasphere - The Dermatology Podcast?

This episode is 1 hour and 24 minutes long.

When was this Dermasphere - The Dermatology Podcast episode published?

This episode was published on February 10, 2020.

Can I download this Dermasphere - The Dermatology Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!